Skip to main navigation
Orchestra BioMed logo

Close

Investor Relations
  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • Investor Relations
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & Filings
    • SEC Filings
    • Annual Reports and Proxy Satements
  • IR Resources
    • Email Alerts
    • Contact IR
  • Contact Us
Menu - sns
Twitter Linkedin

Investor Relations

SEC Filings

Filing date Form Description Filing Group View
Oct 13, 2022 UPLOAD

UPLOAD

Other
View HTML
0000000000-22-011229.pdf
0000000000-22-011229.rtf
Oct 12, 2022 SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
0001193125-22-261298.pdf
0001193125-22-261298.rtf
0001193125-22-261298.xls
Oct 12, 2022 SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
0001193125-22-261301.pdf
0001193125-22-261301.rtf
0001193125-22-261301.xls
Sep 23, 2022 S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML
0001213900-22-058459.pdf
0001213900-22-058459.rtf
0001213900-22-058459.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Sep 23, 2022 CORRESP

CORRESP

Other
View HTML
0001213900-22-058462.pdf
0001213900-22-058462.rtf
Sep 20, 2022 425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
0001213900-22-057423.pdf
0001213900-22-057423.rtf
Sep 20, 2022 425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
0001213900-22-057446.pdf
0001213900-22-057446.rtf
Sep 05, 2022 UPLOAD

UPLOAD

Other
View HTML
0000000000-22-009623.pdf
0000000000-22-009623.rtf
Aug 15, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001213900-22-047919.pdf
0001213900-22-047919.rtf
0001213900-22-047919.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 08, 2022 S-4

Registration of securities issued in business combination transactions

Registration Statements
View HTML
0001213900-22-045485.pdf
0001213900-22-045485.rtf
0001213900-22-045485.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page Next ›
  • Last page Last »
Displaying 61 - 70 of 124 results

Data provided by Kaleidoscope.

Orchestra BioMed logo
  • Footerlink - who we are

    Who We Are Our Approach Our People Careers
  • Footerlink - our innovations

    Our Innovations Pipeline Therapeutic Areas Virtue® SAB BackBeat CNT™ FreeHold Retractors
  • Footerlink - news & events

    Investor Relations Overview News & Events Stock Information Corporate Governance Financial & Filings IR Resources
  • Footerlink - contact us

    Contact Us
Menu - sns
Twitter Linkedin

© 2023 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Btn - disclaimer

Disclaimer